Copyright
©The Author(s) 2024.
World J Psychiatry. Nov 19, 2024; 14(11): 1735-1745
Published online Nov 19, 2024. doi: 10.5498/wjp.v14.i11.1735
Published online Nov 19, 2024. doi: 10.5498/wjp.v14.i11.1735
Figure 1 Trend of changes in brief psychiatric rating scale total score of patients with schizophrenia.
BPRS: Brief psychiatric rating scale.
Figure 2 Major patient-specific predictors on brief psychiatric rating scale reduction.
A: Grouped by baseline brief psychiatric rating scale total scores; B: Grouped by whether or not in the acute phase. BPRS: Brief psychiatric rating scale; LS mean: Least square mean; CI: Confidence interval.
- Citation: Xu BY, Jin K, Wu HS, Liu XJ, Wang XJ, Sang H, Li KQ, Sun MJ, Meng HQ, Deng HL, Xun ZY, Yang XD, Zhang L, Li GJ, Zhang RL, Cai DF, Liu JH, Zhao GJ, Liu LF, Wang G, Zhao CL, Guo B, Jin SC, Huang LY, Yang FD, Zheng JM, Zhan GL, Fang MS, Meng XJ, Zhang GY, Li HM, Liu XL, Li JH, Wu B, Li HY, Chen JD. Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia. World J Psychiatry 2024; 14(11): 1735-1745
- URL: https://www.wjgnet.com/2220-3206/full/v14/i11/1735.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i11.1735